REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.50
Ask: 7.00
Change: 0.75 (12.00%)
Spread: 0.50 (7.692%)
Open: 6.25
High: 7.00
Low: 7.00
Prev. Close: 6.25
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Nov 2012 12:39

28 November 2012 AIM: TLY Totally Plc ("Totally", "the Group" or "the Company") Appointment of Finance Director

The Company is pleased to announce the appointment of Donald (Don) Baladasan as Finance Director and a member of the Board with immediate effect.

Don Baladasan has been working closely with the company since May 2012 on a consultancy basis to help drive the business forward with Clare Wexler (nee Thompson) and the rest of the Totally management team.

Don has extensive experience of working with AIM listed companies and SMEs helping deliver strategic change and raising capital. Relevant sector experience includes healthcare and technology.

Previous positions include Head of Accounting Development of Stemcor Limited, where he was charged with the finance and treasury system development for the Group which had a presence in 46 countries. The Group had a £6bn turnover and £ 24bn in foreign exchange hedges. Prior to this role Don worked at Burson Marsteller AG, BUPA Hospitals and Financial Times.

Don is a qualified Chartered Management Accountant having trained with Financial Times and holds a Economics BSc (Hons) from City University.

Commenting on the appointment of Don Baladasan, Clare Wexler (nee Thompson), Chief Executive Officer of Totally said:

"Don was appointed as a finance consultant to the Company in May 2012 to help formulate and deliver the new business strategy going forward. I am delighted that he has now accepted the formal appointment of Finance Director to the Company.

For further information please contact:

Totally Plc T: 020 7692 6929Clare Wexler Chief Executive Officer Merchant Securities Limited T: 020 7628 2200Lindsay Mair/Richard Goldsmith

Regulatory Information

Under Schedule 2, paragraph (g) of the AIM Rules, the following information is disclosed:

Mr Donald Ahelan Baladasan, aged 39, holds or has held in the last five yearsthe following directorships:Current Directorships Mataxis Ltd TLD Registrar Services Ltd GB.COM Ltd Carecapital Group PLC Carecapital Ltd Whois Privacy Ltd

The Healthcare Property Company Ltd

XLON
Date   Source Headline
7th May 20247:00 amRNSTrading Update
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.